Phase I – Bioequivalence

302 trials 14 recruiting

Filter these 302 trials by condition, country, sponsor and more.

Open in Search →

A Randomised, Open-Label, Single-Centre, Study to Evaluate the Bioequivalence of Lanifibranor Ended

2025-524385-18-00 Non-alcoholic steatohepatitis 2026-02-11
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Clarith… Ended

2024-520153-21-00 Infectious diseases 2026-01-29
Bioequivalence of Testosterone Transdermal Gel in Healthy Female Participants. Ended

2025-523300-77-00 No medical conditions. 2026-01-26
An open label, randomized, single-dose, two-treatment, two-period, cross-over bioequivalence study comparing Pyridostigmine Bromide, P.R.Tab… Ended

2025-524218-27-00 treatment of myasthenia gravis 2026-01-21
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative … Ended

2025-524035-39-00 Bioavailability study in healthy volunteers under fasti 2026-01-14
A double blinded, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover, bioequivalence study comparing Bupr… Ended

2024-516035-27-00 major depressive illness 2026-01-09
Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions. Ended

2025-522626-12-00 No medical condition. 2025-12-18
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin. Ended

2024-519851-27-00 No medical condition. 2025-12-09
A double blinded, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover, bioequivalence study comparing Bupr… Ended

2024-516034-35-00 major depressive illness 2025-12-05
An open label, randomized, single-dose, two-treatment, two-period, cross-over bioequivalence study comparing Pyridostigmine Bromide, P.R.Tab… Ended

2025-524217-89-00 treatment of myasthenia gravis 2025-12-04
Bioequivalence of Cinnarizine/Dimenhydrinate 20 mg/40 mg Tablets in Healthy Participants Under Fed Conditions. Ended

2025-523948-12-00 No medical condition. 2025-11-27
An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared … Ended

2025-523879-34-00 Nicotine use 2025-11-17
Comparison of Prefilled syringe and Autoinjector presentations of FYB202 Ended

2025-522422-13-00 Chronic inflammatory diseases 2025-11-15
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulo… Ended

2024-517642-34-00 Benign prostatic hyperplasia (BPH) 2025-11-10
A Study to Learn How Different Forms of The Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults Ended

2025-522574-36-00 Primary and secondary hypertension, and heart failure 2025-11-04
Single-center, single-dose, open-label, laboratory-blinded, randomized, two-treatment, two-period bioequivalence (BE) study comparing the Te… Ended

2025-523137-25-00 Comparative bioequivalence study in healthy volunteers 2025-11-03
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin. Ended

2024-519849-29-00 No medical condition. 2025-10-27
Randomised, crossover bioequivalence clinical trial of memantine 20 mg capsules versus memantine 20 mg film-coated tablets, after a single o… Ended

2025-523808-75-00 Alzheimer’s disease 2025-10-24
Bioequivalence clinical trial of two formulations of loperamide. Ended

2025-523705-14-00 Healthy volunteers 2025-10-23
An open-label, randomized, single-dose, two-period, two-treatment, crossover bioequivalence study with GP-IMP-001 in healthy male volunteers… Ended

2025-522921-37-00 inteneded for treatment of - active rheumatoid arthriti 2025-10-22
Open-label, randomized, two-period, two-treatment, two-sequence, crossover, balanced, study to assess the bioequivalence between the test pr… Ended

2025-522971-27-00 Bioequivalence study under fasting conditions 2025-10-20
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulo… Ended

2024-517625-72-00 Benign prostatic hyperplasia (BPH) 2025-10-16
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2025-523325-18-00 Bioequivalence study under fasting conditions 2025-10-15
Bioequivalence clinical trial of two formulations of linagliptin Ended

2025-523384-37-00 Healthy volunteers 2025-10-10